DELIVERY ORDER
Expired36C26026F0294
Department of Veterans Affairs › 260-NETWORK CONTRACT OFFICE 20 (36C260)
$151.5K
obligated · signed 5 months ago
ORLADEYO 150MG CAP
Performance timeline
Start
May 19, 2026
End
Sep 30, 2026
with all options
Loading status
This contract has expired. A follow-on may have been awarded.
Search for new solicitations from Department of Veterans Affairs.
BIOCRYST PHARMACEUTICALS INC
Contract 36C26026F0294
UEI
MGXADJ6SCLJ5
Parent Company
BIOCRYST PHARMACEUTICALS INC
Capabilities & Certifications
Headquarters Location
Congressional District: 04
Current Obligation
$151,465
Base + Exercised Options
$151,465
Total Ceiling Value
$151,465
Contract Type
FIRM FIXED PRICE
NAICS
PHARMACEUTICAL PREPARATION MANUFACTURING
PSC
DRUGS AND BIOLOGICALS
Place of Performance
Congressional District: 01
Awarding Agency
Top-tier agency
Department of Veterans Affairs
Sub-tier agency
260-NETWORK CONTRACT OFFICE 20 (36C260)
Office
Funding Agency
Top-tier agency
Department of Veterans Affairs
Sub-tier agency
653-ROSEBURG (00653)
Office
Contract Vehicle
36F79721D0166
FSSDepartment of Veterans Affairs
Award type: MULTIPLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.